Role of radiation therapy in palliative care of the patient with cancer
Radiotherapy is a successful, time-efficient, well-tolerated, and cost-effective intervention
that is crucial for the appropriate delivery of palliative oncology care. The distinction between …
that is crucial for the appropriate delivery of palliative oncology care. The distinction between …
Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies
L Veldeman, I Madani, F Hulstaert… - The lancet …, 2008 - thelancet.com
Since its introduction more than a decade ago, intensity-modulated radiotherapy (IMRT) has
spread to most radiotherapy departments worldwide for a wide range of indications. The …
spread to most radiotherapy departments worldwide for a wide range of indications. The …
[HTML][HTML] Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients
O Grauer, M Jaber, K Hess, M Weckesser… - Journal of neuro …, 2019 - Springer
Background There is an increasing interest in local tumor ablative treatment modalities that
induce immunogenic cell death and the generation of antitumor immune responses …
induce immunogenic cell death and the generation of antitumor immune responses …
A review of the clinical evidence for intensity-modulated radiotherapy
J Staffurth - Clinical oncology, 2010 - Elsevier
AIMS: Intensity-modulated radiotherapy (IMRT) is a development of three-dimensional
conformal radiotherapy that offers improvements in dosimetry in many clinical scenarios …
conformal radiotherapy that offers improvements in dosimetry in many clinical scenarios …
[HTML][HTML] Glioblastoma treatments: an account of recent industrial developments
E Alphandéry - Frontiers in pharmacology, 2018 - frontiersin.org
The different drugs and medical devices, which are commercialized or under industrial
development for glioblastoma treatment, are reviewed. Their different modes of action are …
development for glioblastoma treatment, are reviewed. Their different modes of action are …
Therapeutic options for recurrent malignant glioma
M Niyazi, A Siefert, SB Schwarz, U Ganswindt… - Radiotherapy and …, 2011 - Elsevier
Background and purpose: Despite the given advances in neuro-oncology most patients with
high grade malignant glioma ultimately fail locally or locoregionally. In parallel with …
high grade malignant glioma ultimately fail locally or locoregionally. In parallel with …
Enhancement of therapies for glioblastoma (GBM) using nanoparticle-based delivery systems
K Wiwatchaitawee, JC Quarterman, SM Geary… - Aaps Pharmscitech, 2021 - Springer
Glioblastoma multiforme (GBM) is the most aggressive type of malignant brain tumor.
Current FDA-approved treatments include surgical resection, radiation, and chemotherapy …
Current FDA-approved treatments include surgical resection, radiation, and chemotherapy …
Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme
Abstract Recommendation 1: Multidisciplinary Approach: To optimize treatment outcomes,
the management of patients with recurrent glioblastoma should be individualized and …
the management of patients with recurrent glioblastoma should be individualized and …
Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues
D Amelio, S Lorentini, M Schwarz… - Radiotherapy and …, 2010 - Elsevier
Background and purpose: Intensity-modulated radiation therapy (IMRT) could represent a
new tool to improve the therapeutic ratio in the treatment of glioblastoma. This systematic …
new tool to improve the therapeutic ratio in the treatment of glioblastoma. This systematic …
[HTML][HTML] Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cells
Glioblastoma is deemed the most malignant form of brain tumour, particularly due to its
resistance to conventional treatments. A small surviving group of aberrant stem cells termed …
resistance to conventional treatments. A small surviving group of aberrant stem cells termed …